ZA865842B - Cephalosporin salts and injectable compositions - Google Patents

Cephalosporin salts and injectable compositions

Info

Publication number
ZA865842B
ZA865842B ZA865842A ZA865842A ZA865842B ZA 865842 B ZA865842 B ZA 865842B ZA 865842 A ZA865842 A ZA 865842A ZA 865842 A ZA865842 A ZA 865842A ZA 865842 B ZA865842 B ZA 865842B
Authority
ZA
South Africa
Prior art keywords
injectable compositions
cephalosporin salts
cephalosporin
salts
injectable
Prior art date
Application number
ZA865842A
Inventor
Murray A Kaplan
Thomas W Hudyma
Robert A Lipper
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ZA865842B publication Critical patent/ZA865842B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA865842A 1985-08-05 1986-08-04 Cephalosporin salts and injectable compositions ZA865842B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05

Publications (1)

Publication Number Publication Date
ZA865842B true ZA865842B (en) 1987-04-29

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA865842A ZA865842B (en) 1985-08-05 1986-08-04 Cephalosporin salts and injectable compositions

Country Status (34)

Country Link
JP (1) JPH0615548B2 (en)
KR (1) KR930003121B1 (en)
AR (1) AR243894A1 (en)
AT (1) AT390957B (en)
AU (1) AU597262B2 (en)
BE (1) BE905219A (en)
CA (1) CA1284994C (en)
CH (1) CH675581A5 (en)
CS (2) CS276849B6 (en)
CY (1) CY1614A (en)
DD (2) DD254941A5 (en)
DE (1) DE3626375A1 (en)
DK (1) DK162053C (en)
EG (1) EG18003A (en)
ES (1) ES2002112A6 (en)
FI (1) FI84484C (en)
FR (1) FR2585705B1 (en)
GB (1) GB2179936B (en)
GR (1) GR862055B (en)
HK (1) HK99691A (en)
HU (1) HU196602B (en)
IE (1) IE59222B1 (en)
IL (1) IL79608A (en)
IT (1) IT1197067B (en)
LU (2) LU88574I2 (en)
MY (1) MY102212A (en)
NL (1) NL8601991A (en)
OA (1) OA08672A (en)
PT (1) PT83134B (en)
SE (1) SE469633B (en)
SG (1) SG79791G (en)
SU (1) SU1516013A3 (en)
YU (1) YU45793B (en)
ZA (1) ZA865842B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988010263A1 (en) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
JPH02101081A (en) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd Crystalline dihydrochloride of cephalosporin derivative and production thereof
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
EP0638573A1 (en) * 1993-08-10 1995-02-15 Lucky Ltd. Crystalline hydrates of cephalosporin and process for preparation thereof
DE602004011685T2 (en) 2003-12-23 2009-02-05 Sandoz Gmbh PROCESS FOR PREPARING INTERMEDIATE PRODUCTS FOR USE IN THE CEFALOSPORIN SYNTHESIS
WO2008056221A2 (en) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Crystalline sulfate salt of cephalosporin antibiotic
DE102012101680A1 (en) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmaceutical preparation containing an antiviral dihydroquinazoline derivative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (en) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen METHOD FOR PRODUCING CEPHALOSPORINES
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
FI84484B (en) 1991-08-30
SU1516013A3 (en) 1989-10-15
SG79791G (en) 1991-11-15
CS276717B6 (en) 1992-08-12
DK162053B (en) 1991-09-09
AR243894A1 (en) 1993-09-30
HUT41802A (en) 1987-05-28
YU45793B (en) 1992-07-20
GB2179936B (en) 1989-04-26
PT83134B (en) 1989-07-31
DK371886D0 (en) 1986-08-04
EG18003A (en) 1991-08-30
DK371886A (en) 1987-02-06
IL79608A0 (en) 1986-11-30
DD254941A5 (en) 1988-03-16
FI84484C (en) 1991-12-10
BE905219A (en) 1987-02-04
IE862078L (en) 1987-02-05
AU6069486A (en) 1987-02-12
AT390957B (en) 1990-07-25
CH675581A5 (en) 1990-10-15
LU88574I2 (en) 1995-03-01
DE3626375A1 (en) 1987-02-12
ATA211086A (en) 1990-01-15
FR2585705B1 (en) 1989-01-13
GB8618989D0 (en) 1986-09-17
IT1197067B (en) 1988-11-25
MY102212A (en) 1992-05-15
CY1614A (en) 1992-07-10
IT8621409A1 (en) 1988-02-04
KR930003121B1 (en) 1993-04-19
SE8603308L (en) 1987-02-06
FR2585705A1 (en) 1987-02-06
GB2179936A (en) 1987-03-18
ES2002112A6 (en) 1988-07-16
OA08672A (en) 1989-03-31
CA1284994C (en) 1991-06-18
JPS62103090A (en) 1987-05-13
YU137186A (en) 1987-12-31
HK99691A (en) 1991-12-13
SE469633B (en) 1993-08-09
JPH0615548B2 (en) 1994-03-02
KR880002530A (en) 1988-05-09
DD268395A5 (en) 1989-05-31
DK162053C (en) 1992-02-10
IE59222B1 (en) 1994-01-26
FI863155A (en) 1987-02-06
NL8601991A (en) 1987-03-02
CS276849B6 (en) 1992-08-12
IL79608A (en) 1991-07-18
PT83134A (en) 1986-09-01
FI863155A0 (en) 1986-08-01
HU196602B (en) 1988-12-28
LU86540A1 (en) 1987-03-06
GR862055B (en) 1986-12-24
IT8621409A0 (en) 1986-08-04
AU597262B2 (en) 1990-05-31
SE8603308D0 (en) 1986-08-04

Similar Documents

Publication Publication Date Title
ZA89407B (en) Cephalosporin salts and injectable compositions
NZ215333A (en) Cephem compounds and pharmaceutical compositions
EG18003A (en) Cephalosporin salts and injectable compositions
GB8519452D0 (en) Injectable solutions
PH23045A (en) Cephem derivative and composition containing said compound
NZ212320A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ215717A (en) Cephalosporin derivatives
GR861727B (en) 5-substituted-6-aminopyridine derivatives composition and uses
EP0209751A3 (en) New cephalosporin derivatives and bactericides containing the same
NZ214048A (en) Cephalosporins and pharmaceutical compositions
EP0230052A3 (en) Immunoamplifiers and related compositions
PH23442A (en) Cephalosporin derivatives and salts thereof
GB8608653D0 (en) Particulate composition
NZ210761A (en) Cephalosporin derivatives and pharmaceutical compositions
IL88959A (en) Cephalosporin salts and injectable compositions
IL74822A0 (en) Cephalosporin derivatives and salts thereof and their preparation
PH21201A (en) Cephalosporin derivatives and salts thereof
NZ216624A (en) Cephalosporins and pharmaceutical compositions
HUT44607A (en) Emulsifyer-anti-corrosive additive composition
IL79200A0 (en) Cephalosporin derivatives
IE850448L (en) Cephalosporin derivatives
IL78351A0 (en) Cephalosporin derivatives
ZA862347B (en) Cephalosporin derivatives
IE850040L (en) Cephalosporin derivatives
IE841527L (en) Cephalosporin salts